Clinical Trial Results: HDCRT Plus Pembrolizumab in Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating HDCRT combined with pembrolizumab in advanced solid tumors; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• HDCRT
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: James Larner, MD | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2026-06-15